Abstract
Abnormalities of micturition occur in many different diseases, have a variety of causes and take several forms. This review will focus exclusively on those abnormalities in which antidiuretic therapy may be of benefit. These conditions are primarily characterized by an increase in the total amount of urine produced (polyuria) or a circadian shift in the control of urine production and/or voiding (nocturnal enuresis, nocturia).
(c) 2007 Wiley-Liss, Inc.
MeSH terms
-
Antidiuretic Agents / pharmacology
-
Antidiuretic Agents / therapeutic use*
-
Deamino Arginine Vasopressin / pharmacology
-
Deamino Arginine Vasopressin / therapeutic use
-
Humans
-
Nocturnal Enuresis / drug therapy*
-
Nocturnal Enuresis / physiopathology
-
Polyuria / drug therapy*
-
Polyuria / physiopathology
-
Quality of Life
-
Urination Disorders / drug therapy
-
Urination Disorders / physiopathology
-
Water / metabolism
Substances
-
Antidiuretic Agents
-
Water
-
Deamino Arginine Vasopressin